BeOne Medicines (BEIGF) EBT Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.48 Bn | 625.73 Bn | 17.26 Bn | -265.00 |
| 2 | AbbVie | 442.74 Bn | 436.17 Bn | 12.70 Bn | 636.00 |
| 3 | Merck | 366.39 Bn | 359.25 Bn | 12.21 Bn | 3,137.00 |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn | 625.00 |
| 5 | Pfizer | 158.80 Bn | 147.10 Bn | 10.94 Bn | -2,179.00 |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn | -977.00 |
| 7 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 8 | Incyte | 25.42 Bn | 20.88 Bn | 1.57 Bn | 1,581.00 |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | -861.00 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 8,006.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,006.00 |
| Mar 31, 2026 | 9,237.00 |
| Dec 31, 2025 | 12,335.00 |
| Sep 30, 2025 | 15,263.00 |
| Jun 30, 2025 | 17,081.00 |
| Mar 31, 2025 | 13,925.00 |
| Dec 31, 2024 | 26,667.00 |
| Sep 30, 2024 | 19,997.00 |
| Jun 30, 2024 | 30,900.00 |
| Mar 31, 2024 | -4,260.00 |
| Dec 31, 2023 | 42,620.00 |
| Sep 30, 2023 | 50,700.00 |
| Jun 30, 2023 | 45,292.00 |
| Mar 31, 2023 | 62,278.00 |
| Dec 31, 2022 | 55,514.00 |
| Sep 30, 2022 | 47,979.00 |
| Jun 30, 2022 | -12,879.00 |
| Mar 31, 2022 | 7,789.00 |
| Dec 31, 2021 | 19,492.00 |
| Sep 30, 2021 | 5,767.00 |